Aquatic Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Aquatic Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-85,178	Closed	-$1.79M	–	1523
2025 Q2	$1.79M	Buy	85,178 +36,551	+75%	+$701K	0.04%	498
2025 Q1	$797K	Sell	48,627 -42,562	-47%	-$907K	0.02%	654
2024 Q4	$2.34M	Buy	91,189 +29,189	+47%	+$826K	0.06%	341
2024 Q3	$1.96M	Buy	62,000 +60,100	+3,163%	+$2.28M	0.05%	367
2024 Q2	$66.7K	Buy	+1,900	New	+$75.2K	﹤0.01%	969
2023 Q3	–	Sell	-300	Closed	-$7K	–	1429
2023 Q2	$7K	Buy	+300	New	+$6.17K	﹤0.01%	1223

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Aquatic Capital Management's IDYA Position: Q3 2025 in Review

Aquatic Capital Management sold out of IDEAYA Biosciences (IDYA) in Q3 2025, closing a stake of 85,178 shares — an estimated $1.79M sold.

Aquatic Capital Management first reported a position in IDYA in Q2 2023 and held it in 6 quarters. The position peaked at $2.34M in Q4 2024. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

Aquatic Capital Management reported no remaining IDEAYA Biosciences position as of Q3 2025 after selling out during the quarter.
Aquatic Capital Management sold 85,178 IDEAYA Biosciences shares in Q3 2025, an estimated $1.79M.
Aquatic Capital Management first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 6 quarters.
Aquatic Capital Management's IDEAYA Biosciences position peaked at $2.34M in Q4 2024.
224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on Aquatic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.